JPWO2023145486A1 - - Google Patents

Info

Publication number
JPWO2023145486A1
JPWO2023145486A1 JP2023576781A JP2023576781A JPWO2023145486A1 JP WO2023145486 A1 JPWO2023145486 A1 JP WO2023145486A1 JP 2023576781 A JP2023576781 A JP 2023576781A JP 2023576781 A JP2023576781 A JP 2023576781A JP WO2023145486 A1 JPWO2023145486 A1 JP WO2023145486A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576781A
Other languages
Japanese (ja)
Other versions
JPWO2023145486A5 (enrdf_load_stackoverflow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023145486A1 publication Critical patent/JPWO2023145486A1/ja
Publication of JPWO2023145486A5 publication Critical patent/JPWO2023145486A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2023576781A 2022-01-28 2023-01-13 Pending JPWO2023145486A1 (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022011565 2022-01-28
PCT/JP2023/000786 WO2023145486A1 (ja) 2022-01-28 2023-01-13 フェソテロジンフマル酸塩含有製剤の製造方法

Publications (2)

Publication Number Publication Date
JPWO2023145486A1 true JPWO2023145486A1 (enrdf_load_stackoverflow) 2023-08-03
JPWO2023145486A5 JPWO2023145486A5 (enrdf_load_stackoverflow) 2024-06-26

Family

ID=87471342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576781A Pending JPWO2023145486A1 (enrdf_load_stackoverflow) 2022-01-28 2023-01-13

Country Status (3)

Country Link
JP (1) JPWO2023145486A1 (enrdf_load_stackoverflow)
TW (1) TWI836872B (enrdf_load_stackoverflow)
WO (1) WO2023145486A1 (enrdf_load_stackoverflow)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539802A (ja) * 2006-06-09 2009-11-19 シュバルツ ファルマ アクチェンゲゼルシャフト フェソテロジンを含む安定した医薬組成物
WO2012136839A1 (en) * 2011-04-08 2012-10-11 Lek Pharmaceuticals D.D. Dry formulation and pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
JP2018519305A (ja) * 2015-06-30 2018-07-19 ジェネンテック， インコーポレイテッド 薬物を含有する即放性錠剤及び錠剤の形成プロセス
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
WO2019206391A1 (en) * 2018-04-26 2019-10-31 Rontis Hellas S.A. Extended release pharmaceutical composition containing fesoterodine and process for the preparation thereof
WO2020090969A1 (ja) * 2018-10-31 2020-05-07 富士フイルム株式会社 抗腫瘍剤を含む医薬組成物の包装体

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009539802A (ja) * 2006-06-09 2009-11-19 シュバルツ ファルマ アクチェンゲゼルシャフト フェソテロジンを含む安定した医薬組成物
WO2012136839A1 (en) * 2011-04-08 2012-10-11 Lek Pharmaceuticals D.D. Dry formulation and pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
JP2018519305A (ja) * 2015-06-30 2018-07-19 ジェネンテック， インコーポレイテッド 薬物を含有する即放性錠剤及び錠剤の形成プロセス
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
WO2019206391A1 (en) * 2018-04-26 2019-10-31 Rontis Hellas S.A. Extended release pharmaceutical composition containing fesoterodine and process for the preparation thereof
WO2020090969A1 (ja) * 2018-10-31 2020-05-07 富士フイルム株式会社 抗腫瘍剤を含む医薬組成物の包装体

Also Published As

Publication number Publication date
WO2023145486A1 (ja) 2023-08-03
TWI836872B (zh) 2024-03-21
TW202329927A (zh) 2023-08-01

Similar Documents

Publication Publication Date Title
BR102023014872A2 (enrdf_load_stackoverflow)
BR102023012440A2 (enrdf_load_stackoverflow)
BR102023010976A2 (enrdf_load_stackoverflow)
BR102023009641A2 (enrdf_load_stackoverflow)
BR102023008688A2 (enrdf_load_stackoverflow)
BR102023007252A2 (enrdf_load_stackoverflow)
JPWO2023145486A1 (enrdf_load_stackoverflow)
BR202022009269U2 (enrdf_load_stackoverflow)
BR202022005961U2 (enrdf_load_stackoverflow)
BR202022001779U2 (enrdf_load_stackoverflow)
BR202022000931U2 (enrdf_load_stackoverflow)
CN307045075S (enrdf_load_stackoverflow)
CN306840088S8 (enrdf_load_stackoverflow)
CN307047625S (enrdf_load_stackoverflow)
CN307047495S (enrdf_load_stackoverflow)
CN307047247S (enrdf_load_stackoverflow)
CN307047182S (enrdf_load_stackoverflow)
CN307047166S (enrdf_load_stackoverflow)
CN307047932S (enrdf_load_stackoverflow)
CN307046967S (enrdf_load_stackoverflow)
CN307045889S (enrdf_load_stackoverflow)
CN307045701S (enrdf_load_stackoverflow)
CN307045508S (enrdf_load_stackoverflow)
CN307045321S (enrdf_load_stackoverflow)
BY13160U (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240403

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240403

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250603

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250801